Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...

In another important milestone, PeriVision has signed a clinical trial agreement with Genentech, Roche's US business unit. The aim is to evaluate the potential use of the VisionOne platform in ...

Experienced managers and prominent investors are joining Swiss start-ups. As a result, companies’ networks are becoming ever denser.

Marcel Aumer, CEO, VRP und Co-Founder der FlexBase Group, rechnet trotz der Projektneuauflage nicht mit einer Verzögerung des ambitionierten Zeitplans. Der Baustart ist für Frühling 2025 geplant. Als ...

Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...

Unlike traditional aligners, which often cause oral hygiene problems such as bacteria build-up, bad breath (halitosis) or cavities, Actival incorporates CSEM's patented 3D-printed microchannel ...